Indian Pharma Market grows by 7.9% in July; antibiotic Augmentin rebounds to top spot
New Delhi: The Indian Pharmaceutical Market (IPM) in July underwent a value growth of 7.9 per cent driven by new launches in the anti-diabetic segment and value growth of cardiac…
Novo Nordisk to phase out country’s largest insulin brand
In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, Human Mixtard, among other older insulin brands in India. Human Mixtard…
